Uniqure
Price & Volume
Stats
See moreOpen | $20.90 |
Previous Close | $24.87 |
Day Range | $16.22-$20.90 |
52W Range | $7.76-$71.50 |
Market Cap | $1.5B |
Shares Short | 11M |
Financials
See moreRevenue (12 Mos) | $15.7M |
Revenue Growth (YoY) | 61.8% |
Gross Profit (12 Mos) | -$123.1M |
Diluted EPS | -$4.55 |
News
See moreYahoo Finance • 7 hours ago
Bronstein, Gewirtz & Grossman LLC Urges uniQure N.V. Investors to Act: Class Action Filed Alleging Investor Harm
Yahoo Finance • 21 hours ago
uniQure Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against uniQure N.V. - QURE
Yahoo Finance • 2 days ago
uniQure N.V. Securities Fraud Class Action Result of FDA Approval Delay and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
Yahoo Finance • 6 days ago
QURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit with the Schall Law Firm
About
CEO | Mr. Matthew Craig Kapusta CPA |
CFO | Mr. Christian Klemt |
Address | Paasheuvelweg 25, Amsterdam, Netherlands, 1105 BP |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 209 |
